RecallDepth
Class II Ongoing

Deferasirox Tablets for Oral Suspension, 500mg, 30-count bottle, Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-496-30

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
October 20, 2023
Posted
November 15, 2023
Recall Number
D-0095-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
5,856 bottles
Firm Location
Mahwah, NJ, United States

Reason for Recall

Failed Dissolution Specifications

Distribution

USA nationwide

Lot / Code Info

Lot #: 17220063, Exp 12/2023; 17220396, 17220397, Exp 01/2024; 17220965, Exp 04/2024; 17221187, 17221523, Exp 07/2024; 17221793, 17221794, 17221801, Exp 08/2024

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class II Drug recalls